← Back to Search

Optical Imaging Device

PS-OCT Eye Scan for Retinal Imaging

N/A

Waitlist Available

Led By Benjamin Vakoc, Ph.D.

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects with clear enough cornea or clear enough media to permit imaging

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at time of imaging

Awards & highlights

Study Summary

This trial assesses a new eye scan's ability to see retinal detail.

Who is the study for?

This trial is for men and women aged 18-85 who are generally healthy with no significant eye diseases, except mild cataracts. Participants should have a clear cornea or media allowing for imaging and a refractive error within -5.00 to +5.00 spherical units.Check my eligibility

What is being tested?

The study is testing the effectiveness of a new retinal imaging system called Polarization-Sensitive Optical Coherence Tomography (PS-OCT). It aims to capture high-quality images of the retina's birefringence in healthy subjects.See study design

What are the potential side effects?

Since this trial involves non-invasive imaging technology, there are minimal expected side effects, primarily related to light exposure during retinal scanning which could include temporary discomfort or visual disturbances.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My eyes are clear enough for imaging tests.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at time of imaging

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at time of imaging

This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of imaging for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average nerve fiber layer (NFL) birefringence

Trial Design

1Treatment groups

Experimental Treatment

Group I: Control: HealthyExperimental Treatment1 Intervention

Polarization Sensitive Optical Coherence Tomography (PS-OCT) Imaging will be used to look at the nerve fiber layer (NFL) in the healthy retina.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,335 Total Patients Enrolled

Massachusetts Eye and Ear InfirmaryOTHER

106 Previous Clinical Trials

12,929 Total Patients Enrolled

Benjamin Vakoc, Ph.D.Principal InvestigatorMassachusetts General Hospital

Media Library

Polarization-Sensitive OFDI (Optical Imaging Device) Clinical Trial Eligibility Overview. Trial Name: NCT02441777 — N/A

Healthy Subjects Research Study Groups: Control: Healthy

Healthy Subjects Clinical Trial 2023: Polarization-Sensitive OFDI Highlights & Side Effects. Trial Name: NCT02441777 — N/A

Polarization-Sensitive OFDI (Optical Imaging Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02441777 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation involve any individuals aged 40 and above?

"According to the specifications listed in this clinical trial's eligibility requirements, patients must be 18 years or older and no more than 85."

Answered by AI

Who can participate in this experiment?

"Admission requirements for this trial include being between 18 and 85 years old with healthy subjects. In total, the study is recruiting 20 individuals to participate."

Answered by AI

Is the process of recruiting participants for this experiment still ongoing?

"According to clinicaltrials.gov, this trial has concluded its recruitment stage and is no longer searching for patients. The study was initially posted on the 1st of June 2023 with a final edit made on March 23rd of that same year. Fortunately, there are 1100 other medical studies currently looking for participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging

Benjamin Vakoc 2023. "Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02441777.

All > Penicillin Allergy > Allergy